This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Cognitive Behavioral Therapy for COPD (CLIMB)

This study has been completed.
Icahn School of Medicine at Mount Sinai
Information provided by (Responsible Party):
Lynn Foster Reinke, University of Washington Identifier:
First received: September 24, 2012
Last updated: October 28, 2016
Last verified: October 2016

The purpose of this study in patients with advanced COPD and depression is twofold:

  1. Determine the feasibility and acceptability of a 6-session e-counseling intervention
  2. Determine the efficacy of the e-counseling intervention on depressive symptoms

We hypothesize that patients who participate in e-counseling will have improved depressive symptoms compared to patients receiving usual care at 8 weeks.

Condition Intervention
COPD Depression Behavioral: CLIMB (COPD Lifestyle, Mood, and Behavior)

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Psychosocial-Behavioral Therapy for Patients With Advanced COPD and Depression

Further study details as provided by Lynn Foster Reinke, University of Washington:

Primary Outcome Measures:
  • Depressive Symptoms [ Time Frame: 8 weeks ]
    Personal Health Questionnaire-9

Secondary Outcome Measures:
  • Dyspnea Intensity and Distress [ Time Frame: 8 weeks ]
    Chronic Respiratory Questionnaire, Shortness of Breath Questionnaire, Dyspnea Management Questionnaire

  • Fatigue [ Time Frame: 8 weeks ]
    Chronic Respiratory Questionnaire

  • Anxiety [ Time Frame: 8 weeks ]
    Hospital Anxiety and Depression Scale

  • Physical Activity [ Time Frame: 8 weeks ]
    Accelerometry (Stepwatch)

  • Quality of Life [ Time Frame: 8 weeks ]
    Chronic Respiratory Questionnaire and Medical Outcomes Short Form-36

Enrollment: 18
Study Start Date: September 2012
Study Completion Date: October 2016
Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: CLIMB (COPD Lifestyle, Mood, and Behavior)
Counseling sessions for COPD and depression
Behavioral: CLIMB (COPD Lifestyle, Mood, and Behavior)
Cognitive Behavioral Therapy delivered to patients via telephone aimed to improve mood and decrease depressive symptoms.
No Intervention: Control
Usual Care

Detailed Description:
Chronic obstructive pulmonary disease (COPD) is the third leading cause of the death in the US. Although COPD is mostly preventable, there is no cure. Thus, care of patients with COPD is primarily focused on symptom palliation with the goal of improving quality of life for both patients and their families. These goals are highly consistent with core principles of palliative care. Dyspnea is the most distressing symptom for patients. Even optimal disease-directed treatment provides only partial relief from dyspnea. Depression is consistently associated with worse dyspnea, but the mechanisms underlying this relationship are poorly understood. Since existing treatment for dyspnea has only limited success and there is evidence that treating depression alleviates pain, we propose that by improving mood, we may be more successful in alleviating dyspnea. Psychosocial-behavioral therapy (PBT) which is focused on increasing pleasant events and improving problem solving skills has been shown to have immediate and sustained effects on depressive symptoms in patients with dementia and post-stroke holds tremendous promise for efficacy in advanced COPD. Testing the use of novel technologies to provide efficacious interventions such as PBT to patients with advanced disease is critical for translational palliative care research

Ages Eligible for Study:   40 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • COPD (FEV1/FVC < 70% & FEV1 <80%; current or past smoking >10pack-years)
  • Depressed (PHQ-9 >=10)
  • Ability to speak, read and write English
  • Willingness to use computer or study-issued tablet device

Exclusion Criteria:

  • Current non-nicotine substance abuse or dependence
  • Psychotic disorder
  • Active suicide ideation with intent and plan
  • Alzheimer's/dementia
  • Currently receiving any psychotherapy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01694628

United States, Washington
University of Washington
Seattle, Washington, United States, 98195
Sponsors and Collaborators
University of Washington
Icahn School of Medicine at Mount Sinai
Principal Investigator: Lynn F Reinke, PhD, RN University of Washington
  More Information

Responsible Party: Lynn Foster Reinke, Clinical Associate Professor, University of Washington Identifier: NCT01694628     History of Changes
Other Study ID Numbers: NPCRC Pilot Grant
Study First Received: September 24, 2012
Last Updated: October 28, 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Additional relevant MeSH terms:
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders processed this record on August 23, 2017